S&P 500   3,962.25 (-0.38%)
DOW   32,359.58 (-0.22%)
QQQ   305.37 (-1.10%)
AAPL   156.43 (-1.17%)
MSFT   272.99 (-1.23%)
META   199.55 (-1.62%)
GOOGL   100.84 (-1.58%)
AMZN   96.66 (-1.41%)
TSLA   187.21 (-2.40%)
NVDA   262.00 (-1.25%)
NIO   9.16 (+2.58%)
BABA   97.99 (+13.78%)
AMD   93.85 (-2.86%)
T   18.77 (-0.53%)
F   11.56 (+0.35%)
MU   58.77 (-1.71%)
CGC   1.82 (-3.46%)
GE   92.76 (-0.59%)
DIS   94.82 (-0.84%)
AMC   5.35 (+17.58%)
PYPL   72.20 (-1.50%)
PFE   39.90 (-0.80%)
NFLX   323.10 (-1.39%)
S&P 500   3,962.25 (-0.38%)
DOW   32,359.58 (-0.22%)
QQQ   305.37 (-1.10%)
AAPL   156.43 (-1.17%)
MSFT   272.99 (-1.23%)
META   199.55 (-1.62%)
GOOGL   100.84 (-1.58%)
AMZN   96.66 (-1.41%)
TSLA   187.21 (-2.40%)
NVDA   262.00 (-1.25%)
NIO   9.16 (+2.58%)
BABA   97.99 (+13.78%)
AMD   93.85 (-2.86%)
T   18.77 (-0.53%)
F   11.56 (+0.35%)
MU   58.77 (-1.71%)
CGC   1.82 (-3.46%)
GE   92.76 (-0.59%)
DIS   94.82 (-0.84%)
AMC   5.35 (+17.58%)
PYPL   72.20 (-1.50%)
PFE   39.90 (-0.80%)
NFLX   323.10 (-1.39%)
S&P 500   3,962.25 (-0.38%)
DOW   32,359.58 (-0.22%)
QQQ   305.37 (-1.10%)
AAPL   156.43 (-1.17%)
MSFT   272.99 (-1.23%)
META   199.55 (-1.62%)
GOOGL   100.84 (-1.58%)
AMZN   96.66 (-1.41%)
TSLA   187.21 (-2.40%)
NVDA   262.00 (-1.25%)
NIO   9.16 (+2.58%)
BABA   97.99 (+13.78%)
AMD   93.85 (-2.86%)
T   18.77 (-0.53%)
F   11.56 (+0.35%)
MU   58.77 (-1.71%)
CGC   1.82 (-3.46%)
GE   92.76 (-0.59%)
DIS   94.82 (-0.84%)
AMC   5.35 (+17.58%)
PYPL   72.20 (-1.50%)
PFE   39.90 (-0.80%)
NFLX   323.10 (-1.39%)
S&P 500   3,962.25 (-0.38%)
DOW   32,359.58 (-0.22%)
QQQ   305.37 (-1.10%)
AAPL   156.43 (-1.17%)
MSFT   272.99 (-1.23%)
META   199.55 (-1.62%)
GOOGL   100.84 (-1.58%)
AMZN   96.66 (-1.41%)
TSLA   187.21 (-2.40%)
NVDA   262.00 (-1.25%)
NIO   9.16 (+2.58%)
BABA   97.99 (+13.78%)
AMD   93.85 (-2.86%)
T   18.77 (-0.53%)
F   11.56 (+0.35%)
MU   58.77 (-1.71%)
CGC   1.82 (-3.46%)
GE   92.76 (-0.59%)
DIS   94.82 (-0.84%)
AMC   5.35 (+17.58%)
PYPL   72.20 (-1.50%)
PFE   39.90 (-0.80%)
NFLX   323.10 (-1.39%)
NASDAQ:SILK

Silk Road Medical - SILK Stock Forecast, Price & News

$38.66
+0.01 (+0.03%)
(As of 03/28/2023 02:39 PM ET)
Add
Compare
Today's Range
$38.33
$39.14
50-Day Range
$38.09
$55.57
52-Week Range
$27.30
$58.04
Volume
299,856 shs
Average Volume
505,325 shs
Market Capitalization
$1.49 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.83

Silk Road Medical MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
35.4% Upside
$52.83 Price Target
Short Interest
Bearish
6.06% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.34mentions of Silk Road Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$12.46 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.51) to ($1.32) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars

Medical Sector

645th out of 1,002 stocks

Surgical & Medical Instruments Industry

63rd out of 104 stocks


SILK stock logo

About Silk Road Medical (NASDAQ:SILK) Stock

Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Stock News Headlines

Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Citigroup upgrades Silk Road Medical (SILK) to a Hold
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Q4 2022 Silk Road Medical Inc Earnings Call
SILK Silk Road Medical, Inc
Is Silk Road Medical (SILK) a Great Stock to Invest in?
Silk Road Shares Rise After 3Q Loss Narrows
See More Headlines
Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

SILK Company Calendar

Last Earnings
2/28/2023
Today
3/28/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SILK
Employees
352
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$52.83
High Stock Price Forecast
$70.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+36.4%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$-55,010,000.00
Pretax Margin
-39.68%

Debt

Sales & Book Value

Annual Sales
$138.64 million
Book Value
$4.30 per share

Miscellaneous

Free Float
35,516,000
Market Cap
$1.49 billion
Optionable
Not Optionable
Beta
1.22

Key Executives

  • Erica J. RogersErica J. Rogers
    President, Chief Executive Officer & Director
  • Lucas W. BuchananLucas W. Buchanan
    Chief Financial & Operating Officer
  • Sumaira Macdonald
    Executive Director-Medical
  • Tammy Leitsinger
    VP-Professional Education & Medical Affairs
  • Robert A. Nicholas
    Vice President-Operations & Engineering













SILK Stock - Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares.
View SILK analyst ratings
or view top-rated stocks.

What is Silk Road Medical's stock price forecast for 2023?

4 analysts have issued 1 year price objectives for Silk Road Medical's stock. Their SILK share price forecasts range from $43.00 to $70.00. On average, they predict the company's share price to reach $52.83 in the next year. This suggests a possible upside of 36.4% from the stock's current price.
View analysts price targets for SILK
or view top-rated stocks among Wall Street analysts.

How have SILK shares performed in 2023?

Silk Road Medical's stock was trading at $52.85 on January 1st, 2023. Since then, SILK stock has decreased by 26.7% and is now trading at $38.74.
View the best growth stocks for 2023 here
.

When is Silk Road Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our SILK earnings forecast
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) posted its quarterly earnings results on Tuesday, February, 28th. The company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.37) by $0.03. The firm earned $40.07 million during the quarter, compared to the consensus estimate of $37.35 million. Silk Road Medical had a negative trailing twelve-month return on equity of 63.30% and a negative net margin of 39.81%. Silk Road Medical's revenue for the quarter was up 41.8% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.42) EPS.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $176.00 million-$184.00 million, compared to the consensus revenue estimate of $172.70 million.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), Honeywell International (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Alliancebernstein L.P. (6.86%), Clearbridge Investments LLC (4.39%), American Century Companies Inc. (3.53%), TimesSquare Capital Management LLC (2.51%), Lord Abbett & CO. LLC (2.43%) and Bamco Inc. NY (2.06%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and Tony M Chou.
View institutional ownership trends
.

How do I buy shares of Silk Road Medical?

Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $38.74.

How much money does Silk Road Medical make?

Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.49 billion and generates $138.64 million in revenue each year. The company earns $-55,010,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis.

How many employees does Silk Road Medical have?

The company employs 352 workers across the globe.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 3/28/2023 by MarketBeat.com Staff